A new trading day began on Monday, with Kura Oncology Inc (NASDAQ: KURA) stock price down -1.67% from the previous day of trading, before settling in for the closing price of $18.00. KURA’s price has ranged from $7.41 to $24.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -17.31%. With a float of $64.93 million, this company’s outstanding shares have now reached $74.35 million.
The firm has a total of 142 workers. Let’s measure their productivity. In terms of profitability, gross margin is 31.81%, operating margin of -15450.39%, and the pretax margin is -14311.02%.
Kura Oncology Inc (KURA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kura Oncology Inc is 15.28%, while institutional ownership is 91.97%. The most recent insider transaction that took place on May 20 ’24, was worth 57,916. In this transaction Chief Legal Officer of this company sold 2,615 shares at a rate of $22.15, taking the stock ownership to the 68,979 shares. Before that another transaction happened on Jan 29 ’24, when Company’s SVP, Finance & Accounting sold 2,318 for $17.80, making the entire transaction worth $41,262. This insider now owns 48,093 shares in total.
Kura Oncology Inc (KURA) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.5 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -17.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Here are Kura Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.63 in the next quarter and is forecasted to reach -2.64 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Analysing the last 5-days average volume posted by the [Kura Oncology Inc, KURA], we can find that recorded value of 0.44 million was lower than the volume posted last year of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 29.38%. Additionally, its Average True Range was 0.61.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 2.69%, which indicates a significant decrease from 10.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.18% in the past 14 days, which was lower than the 36.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.44, while its 200-day Moving Average is $20.03. Now, the first resistance to watch is $17.93. This is followed by the second major resistance level at $18.17. The third major resistance level sits at $18.36. If the price goes on to break the first support level at $17.50, it is likely to go to the next support level at $17.31. Now, if the price goes above the second support level, the third support stands at $17.07.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
With a market capitalization of 1.36 billion, the company has a total of 76,181K Shares Outstanding. Currently, annual sales are 0 K while annual income is -152,630 K. The company’s previous quarter sales were 0 K while its latest quarter income was -50,840 K.
